By Irene Gonsalvez, Roey Baror, Peter Fried, Emilio Santarnecchi and Alvaro Pascual-Leone - Current Alzheimer Research 2017.
By Jean Paul Nguyen, Alicia Suarez, Gilles Kemoun, Michel Meignier, Estelle Le Saout , Philippe Damier, Julien Nizard, Jean-Pascal Lefaucheur – 3.1.2017 (English & French)
April 2016, Volume 12, pp 57-64.
July 2013, Volume 9, Issue 4, Supplement , Page P664.
May 2013, Volume 120, Issue 5, pp 813-819.
March 2011, Volume 118, Issue 3, pp 463-471.
neuroAD is an investigational device currently not commercially available in the United States.
neuroAD is CE-cleared and commercially available for the treatment of mild to moderate Alzheimer’s Disease in Europe.